
Robotic surgical systems, medical device manufacturing, applied biotechnology, and biomedical engineering.
Integrated platforms spanning surgical robotics, clinical‑grade device manufacturing, and applied biotechnology. Our biomedical engineering programs cover gene therapy (CRISPR), tissue engineering, artificial organs, precision medicine, and nanomedicine—delivered under rigorous quality and regulatory frameworks.
Robotic surgery systems
Medical device production
Biotechnology solutions
Regulatory and clinical validation
Sterilization and packaging engineering
Post‑market surveillance analytics
Gene therapy and CRISPR
Tissue engineering and artificial organs
Personalized medicine and companion diagnostics
Nanomedicine delivery systems
UDI & eIFU services
Clinical evidence repositories
Device lifecycle management
Yes. We provide design transfer, process validation, and full‑stack manufacturing with rigorous quality systems and applicable regulatory pathways.
Cardiovascular, neurovascular, orthopedics, endovascular, minimally invasive surgery, regenerative medicine, and precision therapeutics.
We implement design controls, risk management, biocompatibility evaluations, and clinical evidence strategies aligned to applicable US/EU regulations.
We support EO, steam, and gamma validation activities along with packaging integrity and distribution testing as part of release readiness plans.
Explore our research, ongoing projects, and detailed technical documentation.